These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 5436796)

  • 21. [Hepato-biliary effect of the rifomycin-isoniazid combination. II. Histological study on tuberculized mice].
    Balea T; Marche C; Marche J
    Therapie; 1970; 25(1):125-30. PubMed ID: 5436794
    [No Abstract]   [Full Text] [Related]  

  • 22. Lack of cross-toxicity between isoniazid and ethionamide in severe cutaneous adverse drug reactions: a series of 25 consecutive confirmed cases.
    Lehloenya RJ; Muloiwa R; Dlamini S; Gantsho N; Todd G; Dheda K
    J Antimicrob Chemother; 2015 Sep; 70(9):2648-51. PubMed ID: 26142408
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Neuropsychiatric incidences in antitubercular treatment consisting of isoniazid or isoniazid and ethionamide (8 cases)].
    Bleandonu G; Boye J
    Ann Med Psychol (Paris); 1969 Jul; 127(2):201-26. PubMed ID: 4254305
    [No Abstract]   [Full Text] [Related]  

  • 24. Osteomalacia during rifampicin and isoniazid therapy is rare in Hong Kong.
    Chan TY
    Int J Clin Pharmacol Ther; 1996 Dec; 34(12):533-4. PubMed ID: 8996847
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Hepatitis induced by combined rifomycin and isoniazid].
    Marche J; Hugues FC; Graisely B; Marche C
    Ann Med Interne (Paris); 1971 Oct; 122(10):1045-54. PubMed ID: 5150725
    [No Abstract]   [Full Text] [Related]  

  • 26. Multiple small bowel perforations in a patient on treatment of tuberculosis.
    Scriven JM; Berry D
    J R Coll Surg Edinb; 1996 Oct; 41(5):353. PubMed ID: 8908966
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Compliance, tolerance and effectiveness of a short chemoprophylaxis regimen for the treatment of tuberculosis].
    Martínez Alfaro E; Solera J; Serna E; Cuenca D; Castillejos ML; Espinosa A; Sáez L
    Med Clin (Barc); 1998 Oct; 111(11):401-4. PubMed ID: 9834911
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Reflex algodystrophic syndrome after tuberculostatic agents].
    Navrátil J
    Fysiatr Revmatol Vestn; 1969 Apr; 47(2):73-81. PubMed ID: 4976438
    [No Abstract]   [Full Text] [Related]  

  • 29. [Problem of the pathogenesis of gastric diseases induced by drugs during antibacterial therapy of pulmonary tuberculosis].
    Reznik SE
    Probl Tuberk; 1967; 45(6):51-5. PubMed ID: 5604890
    [No Abstract]   [Full Text] [Related]  

  • 30. [Detrimental and problematic drug combinations. 3].
    Glogner P
    Internist (Berl); 1970 Oct; 11(10):377-8. PubMed ID: 4920740
    [No Abstract]   [Full Text] [Related]  

  • 31. [Association of ethionamide, isoniazid and ethambutol in the therapy of pulmonary tuberculosis].
    Zanotelli F
    Fracastoro; 1967; 60(6):594-607. PubMed ID: 5617704
    [No Abstract]   [Full Text] [Related]  

  • 32. Improved adherence and less toxicity with rifampin vs isoniazid for treatment of latent tuberculosis: a retrospective study.
    Page KR; Sifakis F; Montes de Oca R; Cronin WA; Doherty MC; Federline L; Bur S; Walsh T; Karney W; Milman J; Baruch N; Adelakun A; Dorman SE
    Arch Intern Med; 2006 Sep; 166(17):1863-70. PubMed ID: 17000943
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PXR-ALAS1: a key regulatory pathway in liver toxicity induced by isoniazid-rifampicin antituberculosis treatment.
    Lyoumi S; Lefebvre T; Karim Z; Gouya L; Puy H
    Clin Res Hepatol Gastroenterol; 2013 Nov; 37(5):439-41. PubMed ID: 23916555
    [No Abstract]   [Full Text] [Related]  

  • 34. [Morphological changes in the bronchi and lungs of healthy rats during prolonged inhalation of antibacterial compounds].
    Kulik NM; Nesterov EN
    Antibiotiki; 1971 Jun; 16(6):546-8. PubMed ID: 5112492
    [No Abstract]   [Full Text] [Related]  

  • 35. Decision-making dilemma in drug-induced acute pancreatitis.
    Yegin EG; Eryuksel E; Giral A; Ceyhan B; Ozdogan OC
    J Dig Dis; 2014 Dec; 15(12):694-7. PubMed ID: 25283755
    [No Abstract]   [Full Text] [Related]  

  • 36. [Neuropsychiatric repercussions of antitubercular treatment with isoniazid, or isoniazid and ethionamide (apropos of 8 cases)].
    Bleandonu G; Boye J
    Ann Med Psychol (Paris); 1969 Jul; 2(2):201-26. PubMed ID: 5385334
    [No Abstract]   [Full Text] [Related]  

  • 37. Clinical relevance of reduced bioavailability of rifampicin.
    Joshi SR
    J Assoc Physicians India; 1999 Sep; 47(9):943-4. PubMed ID: 10778683
    [No Abstract]   [Full Text] [Related]  

  • 38. [Hepato-biliary effect of the rifomycin-prothionamid combination. I. Histological study on the rat].
    Hugues FC; Marche C; Marche J
    Therapie; 1970; 25(1):131-6. PubMed ID: 5436795
    [No Abstract]   [Full Text] [Related]  

  • 39. [Modern chemotherapy of tuberculosis].
    Unholtz K
    Munch Med Wochenschr; 1970 May; 112(21):1003-11. PubMed ID: 5467739
    [No Abstract]   [Full Text] [Related]  

  • 40. [Stevens-Johnson syndrome and toxic epidermal necrolysis after intake of rifampicin-isoniazid: report of 8 cases in HIV-infected patients in Togo].
    Pitche P; Mouzou T; Padonou C; Tchangai-Walla K
    Med Trop (Mars); 2005 Sep; 65(4):359-62. PubMed ID: 16548490
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.